欧米克隆:流行病传播者和封锁煽动者——可以从南非和未来的此类发现中学到什么?

IF 1.7 Q3 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Nepal Journal of Epidemiology Pub Date : 2021-12-01 DOI:10.3126/nje.v11i4.41569
Indrajit Banerjee, Jared Robinson, Indraneel Banerjee, Brijesh Sathian
{"title":"欧米克隆:流行病传播者和封锁煽动者——可以从南非和未来的此类发现中学到什么?","authors":"Indrajit Banerjee,&nbsp;Jared Robinson,&nbsp;Indraneel Banerjee,&nbsp;Brijesh Sathian","doi":"10.3126/nje.v11i4.41569","DOIUrl":null,"url":null,"abstract":"<p><p>The SARS-CoV-2 virus which causes the disease termed COVID-19 ripped through the globe in the latter part of 2019 and has left a state of fear, death and destruction in its wake. The Omicron variant was officially announced by the South African authorities on the 24th of November 2021, with the first confirmed sample of the infection being collected on the 9th of November 2021. The initial cases were flagged as a possible new variant due to the stark differences in the presentation and clinical features of the patients. At the time of Omicron's discovery, the predominant variant circulating within South Africa was the Delta variant B.1.617.2 which typically presented with more severe and distinct symptoms. Omicron spread rapidly within the Southern Africa and abroad, principally South Africa, Botswana, Hongkong and Israel were among the first countries to record cases of the new variant. The first European case of the Omicron variant was confirmed on the 26th of November 2021 in Belgium. Towards the end of November 2021 cases of the new variant had been confirmed and recorded in France, the United Kingdom, Germany, Portugal and Scotland. Additional cases of the Omicron variant have been confirmed in Canada, Australia, India and United States. At this current point in the development of the Omicron upsurge in cases the international community should aim for further vaccinations among their fellow countrymen, but more so vaccine equality should be ensured. Such equality should be ensured in the developing nations as the virus does not respect any boundaries or territories and thus a higher level of vaccination worldwide will confer greater protection to the global community as a whole.</p>","PeriodicalId":43600,"journal":{"name":"Nepal Journal of Epidemiology","volume":null,"pages":null},"PeriodicalIF":1.7000,"publicationDate":"2021-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730344/pdf/","citationCount":"8","resultStr":"{\"title\":\"Omicron: The pandemic propagator and lockdown instigator - what can be learnt from South Africa and such discoveries in future.\",\"authors\":\"Indrajit Banerjee,&nbsp;Jared Robinson,&nbsp;Indraneel Banerjee,&nbsp;Brijesh Sathian\",\"doi\":\"10.3126/nje.v11i4.41569\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The SARS-CoV-2 virus which causes the disease termed COVID-19 ripped through the globe in the latter part of 2019 and has left a state of fear, death and destruction in its wake. The Omicron variant was officially announced by the South African authorities on the 24th of November 2021, with the first confirmed sample of the infection being collected on the 9th of November 2021. The initial cases were flagged as a possible new variant due to the stark differences in the presentation and clinical features of the patients. At the time of Omicron's discovery, the predominant variant circulating within South Africa was the Delta variant B.1.617.2 which typically presented with more severe and distinct symptoms. Omicron spread rapidly within the Southern Africa and abroad, principally South Africa, Botswana, Hongkong and Israel were among the first countries to record cases of the new variant. The first European case of the Omicron variant was confirmed on the 26th of November 2021 in Belgium. Towards the end of November 2021 cases of the new variant had been confirmed and recorded in France, the United Kingdom, Germany, Portugal and Scotland. Additional cases of the Omicron variant have been confirmed in Canada, Australia, India and United States. At this current point in the development of the Omicron upsurge in cases the international community should aim for further vaccinations among their fellow countrymen, but more so vaccine equality should be ensured. Such equality should be ensured in the developing nations as the virus does not respect any boundaries or territories and thus a higher level of vaccination worldwide will confer greater protection to the global community as a whole.</p>\",\"PeriodicalId\":43600,\"journal\":{\"name\":\"Nepal Journal of Epidemiology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.7000,\"publicationDate\":\"2021-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8730344/pdf/\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nepal Journal of Epidemiology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.3126/nje.v11i4.41569\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nepal Journal of Epidemiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3126/nje.v11i4.41569","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 8

摘要

导致COVID-19疾病的SARS-CoV-2病毒于2019年下半年席卷全球,留下了恐惧、死亡和破坏的状态。南非当局于2021年11月24日正式宣布了欧米克隆变异,并于2021年11月9日收集了第一个确诊的感染样本。由于患者的表现和临床特征存在明显差异,最初的病例被标记为可能的新变体。在欧米克隆公司发现时,在南非流行的主要变异是Delta变异B.1.617.2,它通常表现出更严重和明显的症状。欧米克隆在南部非洲和国外迅速传播,主要是南非,博茨瓦纳,香港和以色列是第一批记录新变种病例的国家。欧洲首例欧米克隆变异病例于2021年11月26日在比利时得到确认。到2021年11月底,法国、英国、德国、葡萄牙和苏格兰已确认并记录了新变种病例。在加拿大、澳大利亚、印度和美国已经确认了更多的欧米克隆变异病例。在目前欧米克隆病例激增的发展阶段,国际社会应致力于在其同胞中进一步接种疫苗,但更重要的是应确保疫苗平等。应确保发展中国家的这种平等,因为这种病毒不受任何边界或领土的限制,因此,在世界范围内提高疫苗接种水平将为整个国际社会提供更大的保护。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Omicron: The pandemic propagator and lockdown instigator - what can be learnt from South Africa and such discoveries in future.

The SARS-CoV-2 virus which causes the disease termed COVID-19 ripped through the globe in the latter part of 2019 and has left a state of fear, death and destruction in its wake. The Omicron variant was officially announced by the South African authorities on the 24th of November 2021, with the first confirmed sample of the infection being collected on the 9th of November 2021. The initial cases were flagged as a possible new variant due to the stark differences in the presentation and clinical features of the patients. At the time of Omicron's discovery, the predominant variant circulating within South Africa was the Delta variant B.1.617.2 which typically presented with more severe and distinct symptoms. Omicron spread rapidly within the Southern Africa and abroad, principally South Africa, Botswana, Hongkong and Israel were among the first countries to record cases of the new variant. The first European case of the Omicron variant was confirmed on the 26th of November 2021 in Belgium. Towards the end of November 2021 cases of the new variant had been confirmed and recorded in France, the United Kingdom, Germany, Portugal and Scotland. Additional cases of the Omicron variant have been confirmed in Canada, Australia, India and United States. At this current point in the development of the Omicron upsurge in cases the international community should aim for further vaccinations among their fellow countrymen, but more so vaccine equality should be ensured. Such equality should be ensured in the developing nations as the virus does not respect any boundaries or territories and thus a higher level of vaccination worldwide will confer greater protection to the global community as a whole.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Nepal Journal of Epidemiology
Nepal Journal of Epidemiology PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH-
自引率
10.30%
发文量
13
期刊介绍: The Nepal Journal of Epidemiology is a international journal that encompasses all aspects of epidemiology. The journal encourages communication among those engaged in the research, teaching, and application of epidemiology of both communicable and non-communicable disease, including research into health services and medical care. Also covered are new methods, epidemiological and statistical, for the analysis of data used by those who practise social and preventive medicine. It provides the most up-to-date, original, well designed, well interpreted and significant information source in the multidisciplinary field of epidemiology. We publish manuscripts based on the following sections: 1.Short communications 2.Current research trends 3.Original research 4.Case reports 5.Review articles 6.Letter to editor
期刊最新文献
Clinical features and management approaches for Urinary Incontinence in Older Adults: Evidence from Three Hospitals in Qatar. Identifying Dementia research priority for Qatar national dementia research plan: A Cross-sectional Survey. One year analysis of Prospective Memory Clinics Registry in Qatar: A Critical Tool for Dementia Research and Policy Planning. Preliminary findings from the Delirium and Population Health Informatics Cohort (DELPHIC) - Qatar Study. Urgent need for better quality control, standards and regulation for the Large Language Models used in healthcare domain.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1